XML 17 R5.htm IDEA: XBRL DOCUMENT v3.20.2
Statement of Changes in Stockholders' Equity (Deficit) (Unaudited) - USD ($)
Series 1 Convertible Preferred Stock
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2018 $ 2,558 $ 9,727,124 $ (4,952,443) $ 4,777,239
Balance, shares at Dec. 31, 2018 2,558,419      
Stock-based compensation - stock options 54,382 54,382
Stock-based compensation - restricted stock units 22,500 22,500
Net loss (1,528,056) (1,528,056)
Balance at Mar. 31, 2019 $ 2,558 9,804,006 (6,480,499) 3,326,065
Balance, shares at Mar. 31, 2019 2,558,419      
Stock-based compensation - stock options 79,962 79,962
Stock-based compensation - restricted stock units 22,500 22,500
Net loss (1,428,675) (1,428,675)
Balance at Jun. 30, 2019 $ 2,558 9,906,468 (7,909,174) 1,999,852
Balance, shares at Jun. 30, 2019   2,558,419      
Balance at Dec. 31, 2019 $ 2,628 10,651,073 (12,781,660) (2,127,959)
Balance, shares at Dec. 31, 2019 2,627,533      
Issuance of Series 1 Convertible Preferred Stock, net of offering costs $ 4 25,318,702 25,318,706
Issuance of Series 1 Convertible Preferred Stock, net of offering costs (in shares) 3,879      
Issuance of Common Stock in ArTara Private Placement, net of offering costs $ 285 1,867,295 1,867,580
Issuance of Common Stock in ArTara Private Placement, net of offering costs, shares 284,875      
Issuance of Common Stock in Proteon Private Placement, net of offering costs $ 1,897 12,411,440 12,413,337
Issuance of Common Stock in Proteon Private Placement, net of offering costs, shares   1,896,888      
Reverse business combination $ 1,033 34,531,594 34,532,627
Reverse business combination, shares   1,033,907      
Stock-based compensation - stock options 368,135 368,135
Stock-based compensation - restricted stock units 2,429,672 2,429,672
Net loss (10,060,257) (10,060,257)
Balance at Mar. 31, 2020 $ 4 $ 5,843 87,577,911 (22,841,917) 64,741,841
Balance, shares at Mar. 31, 2020 3,879 5,843,203      
Stock-based compensation - stock options 514,054 514,054
Stock-based compensation - restricted stock units 1,314,668 1,314,668
Net loss (7,140,030) (7,140,030)
Balance at Jun. 30, 2020 $ 4 $ 5,843 $ 89,406,633 $ (29,981,947) $ 59,430,533
Balance, shares at Jun. 30, 2020 3,879 5,843,203